Study Of Microrna 22 Level in Psoriasis Patients” | ||||
| Benha Journal of Applied Sciences | ||||
| Article 13, Volume 9, Issue 1, January 2024, Page 99-102 PDF (443.02 K) | ||||
| Document Type: Original Research Papers | ||||
| DOI: 10.21608/bjas.2024.259674.1302 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Samah Saleh Mohammed  1; Ahmed Abd Allwahab Saleh2; Aliaa Mohamed3; Al Shaimaa Mahmoud Al Tabbakh4
| ||||
| 1Department of Dermatology and Andrology Faculty of Medicine, Benha University | ||||
| 2Assistant Professor of Dermatology, Venerelogy and Andrology Faculty of Medicine, Benha University | ||||
| 3Lecturer of Dermatology,Venerology and Andrology Faculty of Medicine - Benha University | ||||
| 4Assistant Professor of Medical Microbiology and Immunology Faculty of Medicine, Benha University | ||||
| Abstract | ||||
| Objectives: The analysis of psoriasis patients' blood levels of micro-RNA 22 (MiR-22). Context: While MiR-22 has been implicated in the development of other autoimmune disorders, nothing is known about its function in psoriasis and its therapeutic or diagnostic potential. Data Sources: Studies that investigated the potential function of MiR-22 in psoriasis patients up to the year 2023 were located by searching and examining the Medline databases (Pub Med and Medscape). Study Selection: Each study was carefully reviewed by experts in the field to ensure its inclusion. They were considered for inclusion if they met the following requirements: Language used: English for both writing and publication. Second, they are published in publications that undergo a peer review process. Thirdly, describe the possible relationship between psoriasis patients and serum MiR-22 levels. When extracting data, studies were discarded if they did not meet the inclusion criteria. Ethical permission, clear eligibility criteria, suitable controls, sufficient information, and well-defined evaluation measures were all variables in determining the study's quality. For our concerned research outcomes, data were independently extracted from all qualifying studies utilising a data collecting form. Results: psoriasis patients' levels of MiR-22 expression are much lower than those of the control group. | ||||
| Keywords | ||||
| Psoriasis; MiR-22 | ||||
|
Statistics Article View: 135 PDF Download: 113 |
||||
